Inmed Pharmaceuticals INC. (INM) — S-1/A Filings
All S-1/A filings from Inmed Pharmaceuticals INC.. Browse 2 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (2)
-
InMed Pharma Amends S-1 for Continuous Offering
— Aug 1, 2025 Risk: high
InMed Pharmaceuticals Inc. filed an S-1/A on August 1, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a potential capital r -
InMed Pharmaceuticals Files S-1/A Amendment
— Dec 30, 2024 Risk: medium
InMed Pharmaceuticals Inc. filed an S-1/A amendment on December 30, 2024, for its registration statement. The filing relates to a proposed offering of securitie
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX